Artelo Biosciences Statistics

NASDAQ: ARTLHealthcareBiotechnologyUSD

3.37-0.04 (-1.17%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Artelo Biosciences by the numbers

Artelo Biosciences has a market capitalization of $1.8 million based on 547.77K shares outstanding. With trailing EPS of $-136.26, Artelo Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 40.4% below its 50-day average and 86.4% below its 200-day average.

Average daily trading volume is 480.72K shares, or about $1.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ARTL valuation vs. peer median

ARTL compared with the median of 8 peer companies
Metric	ARTL	Peer median	Difference
Market cap	$1.85M	$1.92M	-4%
Avg. volume	480.72K	949.26K	-49%

Peer median across 8 companies: LABT, VBIO, EDVA, CRIS, OGEN, SCNI, GNPX, TCRT.

Valuation

Market cap: $1.85M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-136.26
Shares outstanding: 547.77K

Price and trading

Previous close: 3.41
Open: 3.51
Day range: 3.37 – 3.51
52-week range: 3.33 – 179.19
50-day moving average: 5.65
200-day moving average: 24.85
Beta: —
Volume: 27.21K
Average volume: 480.72K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Aug 11, 2025

Additional statistics

Market Cap: 1.85M
Forward Pe: -3.83
Eps: -136.26
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 179.19
Week52 Low: 3.33
Avg Volume: 480.72K
Shares Outstanding: 547.77K
Ma50: 5.65
Ma200: 24.85
Earnings Date: Aug 11, 2025
Pct From52w High: -98.12%
Pct From52w Low: 1.20%